FXYD1 and heart disorder: In the present study, we provide novel evidence that zDHHC5 expression and palmitoylation are altered in cardiac disease, although this does not directly correlate with a change in the palmitoylation of its substrates NCX1 and PLM (summarised in Figure 6).